psoriatic

Health Canada approves secukinumab for psoriatic arthritis, ankylosing spondylitis
Secukinumab has been approved by Health Canada for adult patients with psoriatic arthritis or ankylosing spondylitis who responded inadequately to prior treatment with conventional therapy, according to a press release from Novartis. [...]
1
Like
Save
Treating to Target in Psoriatic Arthritis
Treating to target is becoming the standard of care in many medical specialities, including rheumatology. The Tight Control of Psoriatic Arthritis (TICOPA) trial has recently provided evidence of the benefit of treating to target in psoriatic arthritis ... [...]
7
Like
Save
Psoriasis and psoriatic arthritis raise gout risk
There is currently no cure for psoriatic arthritis, but treatment options are available. Medical treatments involve the use of anti-inflammatory medications, disease-modifying anti-rheumatic drugs (which slow down disease progression ... [...]
3
Like
Save
Testing and Diagnosis of Psoriatic Arthritis
Psoriatic arthritis is classified as an inflammatory type of arthritis. It belongs to a group of conditions, known as spondyloarthropathies. Accurately diagnosing the disease is important so that appropriate treatment can be initiated. [...]
5
Like
Save
Psoriatic Arthritis Treatment Recommendations
Psoriatic arthritis is a chronic type of inflammatory arthritis which is associated with psoriasis, a skin disease. Symptoms of joint inflammation and psoriasis often do not occur simultaneously though. In most psoriatic arthritis patients, symptoms of ... [...]
4
Like
Save
Secukinumab approved for psoriatic arthritis and ankylosing spondylitis
Novartis announced January 15 that the FDA has approved secukinumab (Cosentyx, Novartis) for psoriatic arthritis (PsA) and active ankylosing spondylitis. The announcement comes a year after the FDA's approval for secukinumab for treatment of adults ... [...]
2
Like
Save
Probiotic Action Offers Treatment Solutions for Psoriatic Arthritis
Of those numbers, experts state that even higher numbers of patients suffering from psoriatic arthritis are dissatisfied with treatment results and are experiencing painful symptoms. As a leader in using probiotics for skin care, Probiotic Action ... [...]
4
Like
Save
Apremilast relieved psoriatic arthritis symptoms in phase 3 study
At week 16, 93% of patients completed the trial, with comparable rates of completion between the treatment groups and placebo group. Significantly more patients who received 20-mg or 30-mg apremilast achieved an ACR20 response rate, with 28% of ... [...]
1
Like
Save
Tampa dermatologist aiming to shed light, ease fears over psoriatic arthritis
A chronic inflammatory arthritis, psoriatic arthritis can range from mild to severe depending on the patient and when it's diagnosed. For most patients, treatment helps to relieve pain, protect joints and maintain mobility. Dr. Forman is the founder of ... [...]
1
Like
Save
Study backs PDE-4 inhibitor for psoriatic arthritis
The 505-person study randomised psoriatic arthritis patients who had failed prior treatment to either 20mg of apremilast twice daily, 30mg of apremilast twice daily or placebo. After 16 weeks, 28% of patients who received the 20mg dose had a 20% ... [...]
1
Like
Save
9 Natural Remedies for Psoriatic Arthritis
When it comes to natural treatments for psoriatic arthritis, there's not a ton of research. Conventional drugs have been shown to delay damage from the disease, but alternative therapies have not. "Many of these supplements or vitamins may ease some of ... [...]
3
Like
Save
Novartis receives FDA nod for ankylosing spondylitis and psoriatic arthritis drug
Novartis announced that the US Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) for the treatment of two new indications - adults with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA). AS and PsA are both ... [...]
3
Like
Save